Ameritas Investment Partners, Inc. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$242,155
-15.9%
11,738
+20.3%
0.01%
-9.1%
Q2 2023$287,900
+43.5%
9,756
+12.0%
0.01%
+37.5%
Q1 2023$200,655
-22.4%
8,7090.0%0.01%
-20.0%
Q4 2022$258,657
+13.0%
8,709
+16.6%
0.01%0.0%
Q3 2022$229,000
+4.6%
7,4690.0%0.01%
+11.1%
Q2 2022$219,000
-4.8%
7,469
+4.7%
0.01%
+12.5%
Q1 2022$230,000
-27.7%
7,1340.0%0.01%
-27.3%
Q4 2021$318,000
-11.7%
7,1340.0%0.01%
-15.4%
Q3 2021$360,000
-35.7%
7,1340.0%0.01%
-35.0%
Q2 2021$560,000
+91.8%
7,134
+39.5%
0.02%
+81.8%
Q1 2021$292,000
-33.8%
5,115
-2.9%
0.01%
-45.0%
Q4 2020$441,000
+121.6%
5,268
-5.2%
0.02%
+122.2%
Q3 2020$199,000
+48.5%
5,5550.0%0.01%
+50.0%
Q2 2020$134,000
+83.6%
5,555
+32.5%
0.01%
+50.0%
Q1 2020$73,0000.0%4,1930.0%0.00%
+33.3%
Q4 2019$73,000
+28.1%
4,193
+13.2%
0.00%0.0%
Q3 2019$57,000
-26.0%
3,7050.0%0.00%
-25.0%
Q2 2019$77,000
-10.5%
3,7050.0%0.00%0.0%
Q1 2019$86,000
+11.7%
3,7050.0%0.00%0.0%
Q4 2018$77,000
-4.9%
3,7050.0%0.00%0.0%
Q3 2018$81,000
+285.7%
3,705
+172.0%
0.00%
+300.0%
Q2 2018$21,000
-22.2%
1,3620.0%0.00%0.0%
Q1 2018$27,0001,3620.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders